1. OP0016 Comparative effectiveness at 1 year of different ANTI-TNF drugs as first biologic dmard in patients with rheumatoid arthritis – results from the nationwide swedish register. (15th June 2017) Authors: Turesson, C; Frisell, T; Dehlin, M; Giuseppe, D Di; Feltelius, N; Kastbom, A; Askling, J Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0669 How do we use biologics in patients with a history of malignancy? an assessment of treatment patterns using scandinavian registers. (15th June 2017) Authors: Chatzidionysiou, K; Aaltonen, K; Nordström, D; Gudbjornsson, B; Grondal, G; Geirsson, AJ; Steingrimsdottir, L; Frisell, T; Askling, J Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1027 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0100 Overall cancer risk in patients with rheumatoid arthritis treated with tnf inhibitors, tocilizumab, abatacept, or rituximab. (15th June 2017) Authors: Wadström, H; Frisell, T; Askling, J Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0652 Assessment of biosimilars using real world data: the complexity of choosing a comparator and understanding uptake. (15th June 2017) Authors: Giuseppe, D Di; Frisell, T; Ernestam, S; Forsblad-d'Elia, H; Lindqvist, E; Lindström, U; Sjöwall, C; Askling, J Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0213 Comparative effectiveness of abatacept, rituximab, tocilizumab and anti-tnf biological dmards in ra: results from the nationwide swedish register. (15th June 2017) Authors: Frisell, T; Dehlin, M; Giuseppe, D Di; Feltelius, N; Kastbom, A; Turesson, C; Askling, J Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A3.07 How well do acpa discriminate and predict ra in the general population -– a study based on 12, 590 population-representative swedish twins. (24th February 2016) Authors: Hensvold, AH; Frisell, T; Magnusson, PKE; Holmdahl, R; Askling, J; Catrina, AI Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Is family history a predictor of response to tumour necrosis factor inhibitors in spondyloarthritis? A Swedish nationwide cohort study. (2nd January 2022) Authors: Morin, M; Hellgren, K; Lindström, U; Frisell, T Journal: Scandinavian journal of rheumatology Issue: Volume 51:Number 1(2022) Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OP0200 Confounding by indication will make NON-TNFI BDMARDS appear more harmful than TNFI bdmards - a nationwide study of channeling in sweden 2010-2014. (15th June 2017) Authors: Frisell, T; Baecklund, E; Bengtsson, K; Giuseppe, D Di; Forsblad-d'Elia, H; Askling, J Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A10.16 Risk for lung cancer in ra and different ra phenotypes: Results from a population-based case-control study. (24th February 2016) Authors: Chatzidionysiou, K; Reynisdottir, G; Joshua, V; Frisell, T; Askling, J; Catrina, AI Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Comparative analysis of first-year fingolimod and natalizumab drug discontinuation among Swedish patients with multiple sclerosis. (January 2016) Authors: Frisell, T; Forsberg, L; Nordin, N; Kiesel, C; Alfredsson, L; Askling, J; Hillert, J; Olsson, T; Piehl, F Journal: Multiple sclerosis Issue: Volume 22:Number 1(2016) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗